Expertise in
10
conditions

Nayoung D. Kim

Daejeon, KR 
Expertise in
10
conditions
Daejeon, KR 

Overview

Nayoung Kim practices practicing medicine in Daejeon, Republic of Korea.

Kim is highly rated in 10 conditions, according to our data. Their clinical expertise encompasses Helicobacter Pylori Infection, Peptic Ulcer, Gastritis, Pancreaticoduodenectomy, and Endoscopy.

They are actively involved in clinical research, co-authoring 383 peer reviewed articles and participating in 6 clinical trials.

Locations

Daejeon, Republic of Korea
Other Locations
Changwon, Republic of Korea
Yongin, Republic of Korea
Seoul, Republic of Korea
Suwon, Republic of Korea
Chinju, Republic of Korea
Chuncheon, Republic of Korea
Gyeonggi-do, Republic of Korea
Cheonan, Republic of Korea
Songnam, Republic of Korea
Daegu, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study
Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Combination product
The Evaluation of OLGA and OLGIM Stage Systems for Prediction of Gastric Cancer Risk and Interaction With Other Risk Factors According to Lauren's Classification
The Evaluation of OLGA and OLGIM Stage Systems for Prediction of Gastric Cancer Risk and Interaction With Other Risk Factors According to Lauren's Classification
Enrollment Status: Completed
Publish Date: April 13, 2023
A Prospective, Single-center, Randomized, Open-label, Parallel Design Clinical Trial to Compare the 14-day Bismuth Quadruple Therapy and 7-day Culture Based Tailored Therapy for the Eradication of Helicobacter as a Rescue 2nd Therapy.
A Prospective, Single-center, Randomized, Open-label, Parallel Design Clinical Trial to Compare the 14-day Bismuth Quadruple Therapy and 7-day Culture Based Tailored Therapy for the Eradication of Helicobacter as a Rescue 2nd Therapy.
Enrollment Status: Terminated
Publish Date: April 13, 2023
Intervention Type: Drug, Procedure
Study Phase: Not Applicable
Long-term Follow-up of Interleukin-1B and H+,K+-ATPase mRNA Expression After Helicobacter Pylori Eradication
Long-term Follow-up of Interleukin-1B and H+,K+-ATPase mRNA Expression After Helicobacter Pylori Eradication
Enrollment Status: Completed
Publish Date: April 13, 2023
Expression of Neurotrophic Factors, Tight Junction Proteins, and Cytokines According to the Irritable Bowel Syndrome Subtype and Sex
Expression of Neurotrophic Factors, Tight Junction Proteins, and Cytokines According to the Irritable Bowel Syndrome Subtype and Sex
Enrollment Status: Completed
Publish Date: March 24, 2020
Intervention Type: Procedure
Study Phase: Not Applicable
A Prospective, Multi-center, Randomized, Open-label, Parallel Design Clinical Trial to Compare 10-day Sequential Therapy and 14-day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
A Prospective, Multi-center, Randomized, Open-label, Parallel Design Clinical Trial to Compare 10-day Sequential Therapy and 14-day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea
Enrollment Status: Completed
Publish Date: May 13, 2019
Intervention Type: Drug
Study Phase: Not Applicable
View 5 Less Clinical Trials

383 Total Publications

Correction: Functional characterization of a novel plant growth-promoting rhizobacterium enhancing root growth and salt stress tolerance.
Correction: Functional characterization of a novel plant growth-promoting rhizobacterium enhancing root growth and salt stress tolerance.
Journal: Scientific reports
Published: October 22, 2025

Frequently Asked Questions about Nayoung D. Kim

Is Nayoung D. Kim a top-rated expert for Helicobacter Pylori Infection?

MediFind is an objective health platform that identifies experts based on real-world data. Nayoung D. Kim is classified as an Distinguished expert for Helicobacter Pylori Infection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Nayoung D. Kim participate in research or clinical trials?

Yes. Nayoung D. Kim has published 383 articles and abstracts on conditions like Helicobacter Pylori Infection. You can view a list of Nayoung D. Kim's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kim's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 58 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile